rs56223054

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014832.5(TBC1D4):​c.1856C>T​(p.Pro619Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00453 in 1,614,104 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 15 hom. )

Consequence

TBC1D4
NM_014832.5 missense

Scores

1
17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.96

Publications

12 publications found
Variant links:
Genes affected
TBC1D4 (HGNC:19165): (TBC1 domain family member 4) This gene is a member of the Tre-2/BUB2/CDC16 domain family. The protein encoded by this gene is a Rab-GTPase-activating protein, and contains two phopshotyrosine-binding domains (PTB1 and PTB2), a calmodulin-binding domain (CBD), a Rab-GTPase domain, and multiple AKT phosphomotifs. This protein is thought to play an important role in glucose homeostasis by regulating the insulin-dependent trafficking of the glucose transporter 4 (GLUT4), important for removing glucose from the bloodstream into skeletal muscle and fat tissues. Reduced expression of this gene results in an increase in GLUT4 levels at the plasma membrane, suggesting that this protein is important in intracellular retention of GLUT4 under basal conditions. When exposed to insulin, this protein is phosphorylated, dissociates from GLUT4 vesicles, resulting in increased GLUT4 at the cell surface, and enhanced glucose transport. Phosphorylation of this protein by AKT is required for proper translocation of GLUT4 to the cell surface. Individuals homozygous for a mutation in this gene are at higher risk for type 2 diabetes and have higher levels of circulating glucose and insulin levels after glucose ingestion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004371673).
BP6
Variant 13-75326374-G-A is Benign according to our data. Variant chr13-75326374-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 436950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBC1D4NM_014832.5 linkc.1856C>T p.Pro619Leu missense_variant Exon 10 of 21 ENST00000377636.8 NP_055647.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBC1D4ENST00000377636.8 linkc.1856C>T p.Pro619Leu missense_variant Exon 10 of 21 2 NM_014832.5 ENSP00000366863.3

Frequencies

GnomAD3 genomes
AF:
0.00336
AC:
511
AN:
152098
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00540
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00325
AC:
807
AN:
248676
AF XY:
0.00343
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.00447
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000649
Gnomad NFE exome
AF:
0.00500
Gnomad OTH exome
AF:
0.00512
GnomAD4 exome
AF:
0.00465
AC:
6804
AN:
1461888
Hom.:
15
Cov.:
31
AF XY:
0.00460
AC XY:
3348
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.00306
AC:
137
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00448
AC:
117
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00130
AC:
112
AN:
86258
European-Finnish (FIN)
AF:
0.000842
AC:
45
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00552
AC:
6141
AN:
1112008
Other (OTH)
AF:
0.00369
AC:
223
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
432
864
1296
1728
2160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00336
AC:
511
AN:
152216
Hom.:
1
Cov.:
32
AF XY:
0.00290
AC XY:
216
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000746
AC:
31
AN:
41538
American (AMR)
AF:
0.00477
AC:
73
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4824
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00540
AC:
367
AN:
68006
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00420
Hom.:
4
Bravo
AF:
0.00339
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000742
AC:
3
ESP6500EA
AF:
0.00647
AC:
54
ExAC
AF:
0.00332
AC:
402
Asia WGS
AF:
0.00144
AC:
6
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00522

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 14, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

TBC1D4-related disorder Benign:1
Jul 02, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.044
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.016
.;.;.;T;T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.32
T;T;T;T;T
MetaRNN
Benign
0.0044
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.6
.;N;N;N;.
PhyloP100
4.0
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
1.3
.;N;N;N;N
REVEL
Benign
0.099
Sift
Benign
0.37
.;T;T;T;T
Sift4G
Benign
0.81
.;T;T;T;.
Polyphen
0.0
.;B;B;B;.
Vest4
0.19, 0.11, 0.13
MVP
0.45
MPC
0.34
ClinPred
0.010
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.043
gMVP
0.13
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56223054; hg19: chr13-75900510; COSMIC: COSV100884917; COSMIC: COSV100884917; API